Eli M. Wallace insider trades

Open-market stock purchases and sales by Eli M. Wallace, Chief Executive Officer at BridgeBio Oncology Therapeutics, Inc, from SEC Form 4 filings since Aug 26, 2025.

Recent trades

DateStockTradeValue
Jan 1, 2026BBOT BridgeBio Oncology Therapeutics, IncBought (not open market)—
Dec 10, 2025BBOT BridgeBio Oncology Therapeutics, IncSold (not open market)$13.9M
Oct 2, 2025BBOT BridgeBio Oncology Therapeutics, IncBought (not open market)—

Companies traded

  • BBOT BridgeBio Oncology Therapeutics, Inc: other filings, last Jan 1, 2026

Get free alerts when Eli M. Wallace files a new trade →